Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Galapagos
Biotech
Ikena and Inmagene choose combined CEO—Chutes & Ladders
Ikena and Inmagene choose combined CEO. Galapagos expands executive island. Trogenix trots out new clinical leaders.
Darren Incorvaia
,
Zoey Becker
Jul 25, 2025 8:30am
Galapagos builds island of cell therapies amid pipeline pruning
Jul 24, 2025 10:59am
Galapagos gets cold feet over plans to split up company
May 13, 2025 6:55am
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Apr 25, 2025 8:30am
AIRNA appoints Elevidys architect as CMO—Chutes & Ladders
Apr 18, 2025 8:30am
Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset
Apr 16, 2025 2:55pm